metoclopramide has been researched along with Soft Tissue Neoplasms in 1 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
Soft Tissue Neoplasms: Neoplasms of whatever cell type or origin, occurring in the extraskeletal connective tissue framework of the body including the organs of locomotion and their various component structures, such as nerves, blood vessels, lymphatics, etc.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Toma, S | 1 |
| Coialbu, T | 1 |
| Biassoni, L | 1 |
| Folco, U | 1 |
| Gatti, C | 1 |
| Canavese, G | 1 |
| Giacchero, A | 1 |
| Rosso, R | 1 |
1 trial available for metoclopramide and Soft Tissue Neoplasms
| Article | Year |
|---|---|
Epidoxorubicin plus ifosfamide in advanced and/or metastatic soft-tissue sarcomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, | 1990 |